Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hartleb

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Gastroenterologie Clinique Et Biologique|January 1, 1994
[Relationships between plasma concentrations of endothelin and the severity of liver cirrhosis]M Hartleb, P Kirstetter, R Moreau, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|March 19, 2018
Serum neutrophil gelatinase-associated lipocalin (NGAL) correlates with clinical and endoscopic activity in ulcerative colitis but fails to predict activity in Crohn's diseaseA Budzynska, M Gawron-Kiszka, E Nowakowska-Dulawa, et al.
Endoscopy|September 30, 2009
Fatal case of biliary cast syndrome in nontransplant patientA Dziurkowska-Marek, M Hartleb, T A Marek, et al.
Transplantation Proceedings|October 15, 2011
Biliary complications after orthotopic liver transplantation: a 5-year experienceR Król, H Karkoszka, J Ziaja, et al.
Research in Experimental Medicine. Zeitschrift Fur Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie|January 1, 1994
Polyerga, a biological response modifier enhancing T-lymphocyte-dependent responsesG de Ojeda, R Diez-Orejas, P Portolés, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Spleen peptides (Polyerga) inhibit development of artificial lung metastases of murine mammary carcinoma and increase efficiency of chemotherapy in miceN Zarkovic, M Hartleb, K Zarkovic, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|August 19, 2017
Fibroblast growth factor-21 and omentin-1 hepatic mRNA expression and serum levels in morbidly obese women with non-alcoholic fatty liver diseaseM Waluga, M Kukla, M Zorniak, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Gastroenterologie Clinique Et Biologique|January 1, 1994
[Relationships between plasma concentrations of endothelin and the severity of liver cirrhosis]M Hartleb, P Kirstetter, R Moreau, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|March 19, 2018
Serum neutrophil gelatinase-associated lipocalin (NGAL) correlates with clinical and endoscopic activity in ulcerative colitis but fails to predict activity in Crohn's diseaseA Budzynska, M Gawron-Kiszka, E Nowakowska-Dulawa, et al.
Endoscopy|September 30, 2009
Fatal case of biliary cast syndrome in nontransplant patientA Dziurkowska-Marek, M Hartleb, T A Marek, et al.
Transplantation Proceedings|October 15, 2011
Biliary complications after orthotopic liver transplantation: a 5-year experienceR Król, H Karkoszka, J Ziaja, et al.
Research in Experimental Medicine. Zeitschrift Fur Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie|January 1, 1994
Polyerga, a biological response modifier enhancing T-lymphocyte-dependent responsesG de Ojeda, R Diez-Orejas, P Portolés, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Spleen peptides (Polyerga) inhibit development of artificial lung metastases of murine mammary carcinoma and increase efficiency of chemotherapy in miceN Zarkovic, M Hartleb, K Zarkovic, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|August 19, 2017
Fibroblast growth factor-21 and omentin-1 hepatic mRNA expression and serum levels in morbidly obese women with non-alcoholic fatty liver diseaseM Waluga, M Kukla, M Zorniak, et al.
Pageof 10